DNA Diagnostics Market Report

DNA Diagnostics Market Analysis By Technology (Microarray Based, PCR Based, In-situ Hybridization, NGS DNA Diagnosis), By Application (Pre-natal DNA Carrier Screening, Pre-implantation Diagnosis, Newborn Genetic Screening, Infectious Disease Diagnostics (HBV, HCV, HIV, TB, CT/NG, HPV, & MRSA), Oncology Diagnostics & Histopathology, Identity Diagnostics & Forensics, Pharmacogenomics Diagnostic Testing, & Drug Metabolism/P450 Effects), And Segment Forecasts To 2022

  • Published Date: Jan, 2016
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-676-9
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 148

Table of Contents

Chapter 1. Methodology and Scope
               1.1. Research Methodology
               1.2. Research Scope & Assumptions
               1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. DNA Diagnostics/Testing Industry Outlook
               3.1. Market Segmentation
               3.2. Market Size and Growth Prospects
                  3.2.1. Market Driver Analysis
                  3.2.2. Market Restraint Analysis
               3.3. DNA Diagnostics/Testing Market Dynamics
               3.4. Key Opportunities Prioritized Technology Based
               3.5. Key Opportunities Prioritized Application Based
               3.6. Technology Positioning, 2014
                  3.6.1. Accuracy /Dynamic range
                  3.6.2. Price / cost per sample
                  3.6.3. Availability
                  3.6.4. Complexity
                  3.6.5. Technological advancements
                  3.6.6. Applications
                  3.6.7. Time consumption
               3.7. Competitive Landscape for Companies, 2014 (Subject to data availability)
               3.8. Industry Analysis - Porter’s
               3.9. DNA Diagnostics/Testing Market PESTEL Analysis
Chapter 4. DNA Diagnostics/Testing Technology Outlook
               4.1. PCR Based Diagnostics
                  4.1.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               4.2. NGS DNA Diagnosis
                  4.2.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               4.3. In-situ Hybridization Diagnostics
                  4.3.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               4.4. Micro-arrays Based Diagnostics
                  4.4.1. Market Estimates and Forecasts, 2012 - 2022(USD Million)
Chapter 5. DNA Diagnostics/Testing Application Outlook
               5.1. Pre-natal DNA Carrier Screening
                  5.1.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.2. Pre-implantation Diagnosis
                  5.2.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.3. New-born Genetic Screening
                  5.3.1. Market Estimates and Forecasts, 2012 - 2022(USD Million)
               5.4. Infectious Disease Diagnostics
                  5.4.1. Infectious Diseases Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.2. HBV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.2.1. HBV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.3. HCV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.3.1. HCV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.4. HIV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.4.1. HIV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.5. TB Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.5.1. TB Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.6. CT/NG Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.6.1. CT/NG Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.7. HPV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.7.1. HPV Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.8. MRSA Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.8.1. MRSA Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                  5.4.9. Other Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
                        5.4.9.1. Other Diagnostics Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.5. Oncology Diagnostics & Histopathology
                  5.5.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.6. Identity Diagnostics & Forensics
                  5.6.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.7. Pharmacogenomics Diagnostic Testing
                  5.7.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.8. Drug Metabolism & P450 Effects
                  5.8.1. Market Estimates and Forecasts, 2012 - 2022 (USD Million)
               5.9. Others
                  5.9.1. Others Market Estimates and Forecasts, 2012 - 2022 (USD Million)
Chapter 6. DNA Diagnostics/Testing Regional Outlook (Revenue, USD Million, 2012 - 2022)
               6.1. North America
                  6.1.1. U.S.
                        6.1.1.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.1.1.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
                  6.1.2. Canada
                        6.1.2.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.1.2.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
               6.2. Europe
                  6.2.1. Germany
                        6.2.1.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.2.1.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
                  6.2.2. UK
                        6.2.2.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.2.2.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
               6.3. Asia Pacific
                  6.3.1. China
                        6.3.1.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.3.1.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
                  6.3.2. Japan
                        6.3.2.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.3.2.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
               6.4. Latin America
                  6.4.1. Brazil
                        6.4.1.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.4.1.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
               6.5. MEA
                  6.5.1. South Africa
                        6.5.1.1. DNA Diagnostics/Testing Market, by Technology, 2012 - 2022 (USD Million)
                        6.5.1.2. DNA Diagnostics/Testing Market, by Application, 2012 - 2022 (USD Million)
Chapter 7. Competitive Landscape
               7.1. 454 Life Sciences
                  7.1.1. Company Overview
                  7.1.2. Revenue Analysis
                  7.1.3. Product Benchmarking
                  7.1.4. Strategic Development
               7.2. Abbott Laboratories
                  7.2.1. Company Overview
                  7.2.2. Revenue Analysis
                  7.2.3. Product Benchmarking
                  7.2.4. Strategic Development
               7.3. Affymetrix Inc.
                  7.3.1. Company Overview
                  7.3.2. Revenue Analysis
                  7.3.3. Product Benchmarking
                  7.3.4. Strategic Development
               7.4. Agilent Technologies Inc.
                  7.4.1. Company Overview
                  7.4.2. Revenue Analysis
                  7.4.3. Product Benchmarking
                  7.4.4. Strategic Development
               7.5. Applied Biosystems Group
                  7.5.1. Company Overview
                  7.5.2. Revenue Analysis
                  7.5.3. Product Benchmarking
                  7.5.4. Strategic Development
               7.6. Thermo Fisher Scientific Inc.
                  7.6.1. Company Overview
                  7.6.2. Revenue Analysis
                  7.6.3. Product Benchmarking
                  7.6.4. Strategic Development
               7.7. Illumina Inc.
                  7.7.1. Company Overview
                  7.7.2. Revenue Analysis
                  7.7.3. Product Benchmarking
                  7.7.4. Strategic Development
               7.8. Cepheid Inc.
                  7.8.1. Company Overview
                  7.8.2. Revenue Analysis
                  7.8.3. Product Benchmarking
                  7.8.4. Strategic Development
               7.9. Hologic
                  7.9.1. Company Overview
                  7.9.2. Revenue Analysis
                  7.9.3. Product Benchmarking
                  7.9.4. Strategic Development
               7.10. Bio-Rad Laboratories
                  7.10.1. Company Overview
                  7.10.2. Revenue Analysis
                  7.10.3. Product Benchmarking
                  7.10.4. Strategic Development
               7.11. Dako
                  7.11.1. Company Overview
                  7.11.2. Revenue Analysis
                  7.11.3. Product Benchmarking
                  7.11.4. Strategic Development
               7.12. Alere Inc.
                  7.12.1. Company Overview
                  7.12.2. Revenue Analysis
                  7.12.3. Product Benchmarking
                  7.12.4. Strategic Development
               7.13. Roche Diagnostics
                  7.13.1. Company Overview
                  7.13.2. Revenue Analysis
                  7.13.3. Product Benchmarking
                  7.13.4. Strategic Development
               7.14. Beckman Coulter Inc.
                  7.14.1. Company Overview
                  7.14.2. Revenue Analysis
                  7.14.3. Product Benchmarking
                  7.14.4. Strategic Development
               7.15. Siemens Healthcare
                  7.15.1. Company Overview
                  7.15.2. Revenue Analysis
                  7.15.3. Product Benchmarking
                  7.15.4. Strategic Development


List of Tables

1. DNA diagnostics/testing market - Industry Snapshot & Key Buying Criteria, 2012 - 2022
2. Global DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
3. Global DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
4. Global DNA diagnostics/testing market, by region, 2012 - 2022 (USD Million)
5. DNA diagnostics/testing- Key market driver analysis
6. DNA diagnostics/testing- Key market restraint analysis
7. Rating scale for product positioning
8. Competitive landscape of companies, 2014
9. North America DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
10. North America DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
11. North America DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
12. U.S. DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
13. U.S. DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
14. U.S. DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
15. Canada DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
16. Canada DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
17. Canada DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
18. Europe DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
19. Europe DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
20. Europe DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
21. Germany DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
22. Germany DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
23. Germany DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
24. UK DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
25. UK DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
26. UK DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
27. Asia Pacific DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
28. Asia Pacific DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
29. Asia Pacific DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
30. Japan DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
31. Japan DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
32. Japan DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
33. China DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
34. China DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
35. China DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
36. Latin America DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
37. Latin America DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
38. Latin America DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
39. Brazil DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
40. Brazil DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
41. Brazil DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
42. Mexico DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
43. Mexico DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
44. Mexico DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
45. MEA DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
46. MEA DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
47. MEA DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)
48. South Africa DNA diagnostics/testing market, by technology, 2012 - 2022 (USD Million)
49. South Africa DNA diagnostics/testing market, by application, 2012 - 2022 (USD Million)
50. South Africa DNA infectious disease diagnostics market, by application, 2012 - 2022 (USD Million)


List of Figures

1. DNA diagnostics/testing market segmentation
2. Global DNA diagnostics/testing market, 2012 - 2022 (USD Million)
3. DNA diagnostics/testing market dynamics
4. Key opportunities prioritized, application based
5. Key opportunities prioritized, technology based
6. Technology positioning: On the basis of accuracy
7. Technology positioning: On the basis of price
8. Technology positioning: On the basis of availability
9. Technology positioning: On the basis of complexity
10. Technology positioning: On the basis of technological advancements
11. Technology positioning: On the basis of applications
12. Technology positioning: On the basis of time consumption
13. DNA diagnostics/testing market - Porter’s Analysis
14. DNA diagnostics/testing market - PESTEL analysis
15. DNA diagnostics/testing revenue share, by technology, 2014 & 2022
16. Global microarray based diagnostics market, 2012 - 2022 (USD Million)
17. Global PCR based diagnostics market, 2012 - 2022 (USD Million)
18. Global in-situ hybridization market, 2012 - 2022 (USD Million)
19. Global next generation sequencing market, 2012 - 2022 (USD Million)
20. DNA diagnostics/testing revenue share, by application, 2014 & 2022
21. Global pre-natal DNA carrier screening market, 2012 - 2022 (USD Million)
22. Global pre-implantation genetic diagnosis market, 2012 - 2022 (USD Million)
23. Global new-born genetic screening market, 2012 - 2022 (USD Million)
24. Global infectious disease diagnostics market, 2012 - 2022 (USD Million)
25. Global HBV diagnostics market, 2012 - 2022 (USD Million)
26. Global HCV diagnostics market, 2012 - 2022 (USD Million)
27. Global HIV diagnostics market, 2012 - 2022 (USD Million)
28. Global TB diagnostics market, 2012 - 2022 (USD Million)
29. Global CT/NG diagnostics market, 2012 - 2022 (USD Million)
30. Global HPV diagnostics market, 2012 - 2022 (USD Million)
31. Global MRSA diagnostics market, 2012 - 2022 (USD Million)
32. Global others diagnostics market, 2012 - 2022 (USD Million)
33. Global oncology diagnostics & histopathology market, 2012 - 2022 (USD Million)
34. Global identity diagnostics & forensics market, 2012 - 2022 (USD Million)
35. Global pharmacogenomics diagnostic testing market, 2012 - 2022 (USD Million)
36. Global drug metabolism & P450 effects market, 2012 - 2022 (USD Million)
37. Global others market, 2012 - 2022 (USD Million)
38. DNA diagnostics/testing revenue share, by region, 2014 & 2022
39. North America DNA diagnostics/testing market, 2012 - 2022 (USD Million)
40. U.S. America DNA diagnostics/testing market, 2012 - 2022 (USD Million)
41. Canada DNA diagnostics/testing market, 2012 - 2022 (USD Million)
42. Europe DNA diagnostics/testing market, 2012 - 2022 (USD Million)
43. Germany DNA diagnostics/testing market, 2012 - 2022 (USD Million)
44. UK DNA diagnostics/testing market, 2012 - 2022 (USD Million)
45. Asia Pacific DNA diagnostics/testing market, 2012 - 2022 (USD Million)
46. Japan DNA diagnostics/testing market, 2012 - 2022 (USD Million)
47. Japan DNA diagnostics/testing market, 2012 - 2022 (USD Million)
48. Latin America DNA diagnostics/testing market, 2012 - 2022 (USD Million)
49. Brazil DNA diagnostics/testing market, 2012 - 2022 (USD Million)
50. Mexico DNA diagnostics/testing market, 2012 - 2022 (USD Million)
51. MEA DNA diagnostics/testing market, 2012 - 2022 (USD Million)
52. South Africa DNA diagnostics/testing market, 2012 - 2022 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.